Classification of Pancreatic Hormones
The hormonal profile of the organ can be divided into two major functional groups. The first group is responsible for systemic carbohydrate and lipid metabolism, adapting the body to food intake. The second group specializes in regulating the secretory activity of the pancreas itself, while also influencing the gastrointestinal tract and hemodynamics.
Regulation of Carbohydrate and Lipid Metabolism
Two classic antagonistic hormones are responsible for maintaining energy balance. Their secretion directly depends on the body's current energy demands.
- Insulin. This is a key anabolic hormone that acts actively after a meal. Its main task is to facilitate the transport of nutrient substrates (glucose, amino acids, and fatty acids) from the bloodstream into tissues. Insulin triggers the synthesis of tissue reserves: it stimulates the formation of glycogen, proteins, and fats. A logical result of its action is a pronounced decrease in blood glucose concentration.
- Glucagon. It has the opposite, catabolic effect and comes to the forefront between meals (in the fasting state). It stimulates the mobilization of stored carbohydrates and fats from tissues, returning them to the bloodstream. As a result, blood glucose concentration increases, providing organs with necessary energy.
Regulation of Pancreatic and GI Functions
This group of biologically active substances locally controls digestion, enzyme secretion, and vascular tone.
- Somatostatin. Acts as a universal inhibitor. It is produced not only in the pancreas but also in the GI mucosa and the hypothalamus. The mechanism of its action consists of the total suppression of the production of other hormones and enzymes:
- In the pituitary gland, it inhibits the secretion of growth hormone (GH).
- In the pancreas, it suppresses the release of insulin and glucagon.
- In the GI tract, it blocks the production of gastrin and secretin (furthermore, secretin normally stimulates the exocrine part of the gland).
Outcome: somatostatin inhibits the work of both parts of the pancreas — endocrine and exocrine.
- Vasoactive Intestinal Polypeptide (VIP). Acts as a functional antagonist of somatostatin at the level of the pancreas itself. It actively stimulates the secretion of pancreatic juice and local hormones. In addition, VIP causes blood vessel dilation (vasodilation), leading to a systemic drop in blood pressure.
- Pancreatic Polypeptide (PP). Its functional effect consists in the direct stimulation of digestive juice secretion — both pancreatic and gastric.